|
Overview
The ERGOMED Group is a pan-European Clinical Development Company,
providing full clinical trial-related services to developers of
medical drugs. ERGOMED can assist with strategic clinical development
planning, individual study design, project management and monitoring,
study site management, drug safety monitoring and pharmacovigilance,
medical writing as well as data management, biostatistics, regulatory
assistance and other services. In addition, ERGOMED has access to its
own Phase 1 unit for healthy volunteer studies as well as those in special
populations and early phase oncology studies
With its headquarters in Frankfurt and its nine operational centers in London,
Moscow, Zagreb, Novi Sad, Krakow, Madrid, San Antonio, Geneva and Dubai the
ERGOMED Group currently conducts operations in over 20 different European countries and also MENA (Middle East and North America).
ERGOMED specializes in the fields of Oncology/Hematology and Neurology, with added
strengths in Endocrinology and Immunology while retaining experience in many other
therapeutic areas and indications.
ERGOMED provides clinical development services to some of the world’s
largest pharmaceutical companies as well as to many small- and mid-sized
drug development companies and has been responsible for the pivotal studies
of several drugs including a number of oncologics which have gone on to
receive European regulatory approval. ERGOMED’s success is due largely to
its motivated, highly trained, experienced and dedicated workforce. The
company has grown to around 100 employees, one-quarter of whom hold doctorates
in medicine or in life sciences.
ERGOMED has never had a trial contract cancelled or suspended, many
clients have signed up for repeat business. In fact, a significant minority
of its contracted opportunities have come from ‘rescue’ operations, taking
over clinical trial responsibilities from CROs which have not performed
according to project plans or expectations. In addition, a number of
referrals have come from other CROs with which ERGOMED has collaborated,
an important indication of ‘peer certification’. Finally, ERGOMED has
successfully passed all audits performed by its clients and by
independent authorities.
While ERGOMED prides itself on providing services across the spectrum
of the pharmaceutical industry, the company has particular experience
in working with biotech. ERGOMED is well placed to partner emerging and
developing companies in this sector.
|
